Press "esc" to clear
Go to Advanced Search
Showing results 2130 of 1437
logo-ortho-clinical-diagnostics-black.jpg

Article ID: 698285

FDA Approves Ortho Clinical Diagnostics VITROS® Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator on the VITROS® 3600 Immunodiagnostic System

70th AACC Annual Scientific Meeting Press Program

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS® HIV Combo test) received approval from the U.S. Food and Drug Administration for use on Ortho’s VITROS 3600 Immunodiagnostic System

Released:
30-Jul-2018 5:05 PM EDT
logo-ortho-clinical-diagnostics-black.jpg

Article ID: 698288

Edison Awards Recognize Ortho Clinical Diagnostics’ VITROS® NEPHROCHECK® Test for Best New Product

70th AACC Annual Scientific Meeting Press Program

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced it was selected for a gold-level Edison Award™ in the Best New Product Awards™ category for its VITROS® NEPHROCHECK® Test

Released:
30-Jul-2018 5:05 PM EDT
logo-ortho-clinical-diagnostics-black.jpg

Article ID: 698287

FDA Approves Two Ortho Clinical Diagnostics Specialty Hepatitis B Assays

70th AACC Annual Scientific Meeting Press Program

Ortho Clinical Diagnostics received approval from the U.S. Food and Drug Administration for Ortho’s VITROS® Immunodiagnostic Products HBeAg Assay and the VITROS® Immunodiagnostic Products Anti-HBe Assay for use on the VITROS® 3600 Immunodiagnostic System and VITROS® 5600 Integrated System

Released:
30-Jul-2018 5:05 PM EDT
logo-ortho-clinical-diagnostics-black.jpg

Article ID: 698279

Ortho Clinical Diagnostics VITROS® NEPHROCHECK® Test for Prediction of Acute Kidney Injury Cleared, Available in Europe

70th AACC Annual Scientific Meeting Press Program

Ortho Clinical Diagnostics announced that its VITROS® NEPHROCHECK® test received CE Mark. The VITROS® NEPHROCHECK® test is the first fully automated risk assessment tool for predicting Acute Kidney Injury (AKI), a serious and potentially fatal condition affecting hospital patients worldwide

Released:
30-Jul-2018 4:35 PM EDT
logo-ortho-clinical-diagnostics-black.jpg

Article ID: 698275

VITROS® XT 7600 Integrated System from Ortho Clinical Diagnostics Receives CE Mark, Bringing Innovative New Approach to Clinical Lab Management

70th AACC Annual Scientific Meeting Press Program

Ortho Clinical Diagnostics’ VITROS® XT 7600 Integrated System received CE Mark. By combining Ortho’s proprietary dry slide technology with sophisticated digital imaging and the potential to perform two separate lab tests simultaneously, Ortho introduces digital chemistry to clinical lab management

Released:
30-Jul-2018 4:05 PM EDT
logo-ortho-clinical-diagnostics-black.jpg

Article ID: 698283

Ortho Clinical Diagnostics and Thermo Fisher Scientific Agree to Deliver 14 Assays for Use on Ortho's VITROS® Systems

70th AACC Annual Scientific Meeting Press Program

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced an international distribution and co-promotion agreement with Thermo Fisher Scientific to provide 14 assays used to monitor therapeutic drugs, immunosuppressive drugs and drugs of abuse.

Released:
30-Jul-2018 4:05 PM EDT
logo-ortho-clinical-diagnostics-black.jpg

Article ID: 698270

Ortho Clinical Diagnostics to Unveil Next-Generation Analyzer at AACC and Share Research on IVDs for application in Cardiology, Infectious Disease and Endocrinology

70th AACC Annual Scientific Meeting Press Program

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it will officially unveil the VITROS® XT 7600 Integrated System, now available in numerous countries that accept CE Mark, at the 2018 AACC Annual Scientific Meeting & Clinical Lab Expo

Released:
30-Jul-2018 3:05 PM EDT

Article ID: 698246

Sysmex Celebrates 50th Anniversary, Shares Plans for Innovative Technology to Equip Clinical Lab of the Future, at 2018 AACC

70th AACC Annual Scientific Meeting Press Program

Sysmex, one of the fastest growing providers of diagnostic hardware and software in the U.S., celebrates its 50th anniversary in booth number 1231 at this year’s annual meeting of the American Association for Clinical Chemistry (AACC). The company is also sharing its plans to equip the clinical laboratory of the future with innovative solutions in flow cytometry, urinalysis and hematology.

Released:
30-Jul-2018 1:05 PM EDT

Article ID: 698245

MedTest Dx Releases Two Innovative Solutions for the Growing Higher Throughput Segment of the Decentralized Testing Market at 2018 AACC Scientific Meeting

70th AACC Annual Scientific Meeting Press Program

Responding to customer requirements to handle increased volumes in decentralized clinical testing, MedTest Dx today announced the introduction of its BA-800M Clinical Analyzer for general chemistry with a full line of reagents and the launch of its BC-5390 5-Part Differential Hematology Analyzer at the 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting.

Released:
30-Jul-2018 1:05 PM EDT

Article ID: 698241

Fujirebio Diagnostics Announces FDA Clearance of Lumipulse G B•R•A•H•M•S PCT Assay

70th AACC Annual Scientific Meeting Press Program

Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received U.S. Food and Drug Administration (FDA) clearance of the company’s Lumipulse® G B•R•A•H•M•S PCT Assay for testing on its LUMIPULSE® G1200 immunoassay platform.

Released:
30-Jul-2018 12:05 PM EDT

Showing results 2130 of 1437

Chat now!